Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra

By Howells D.W.   Porritt M.J.   Wong J.Y.F.   Batchelor P.E.   Kalnins R.   Hughes A.J.   Donnan G.A.  

Experimental Neurology, Vol. 166, Iss. 1, 2000-11 ,pp. : 127-135

Elsevier

Access to resources Recommend Favorite

ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia

By Galter D.   Buervenich S.   Carmine A.   Anvret M.   Olson L.  

Neurobiology of Disease, Vol. 14, Iss. 3, 2003-12 ,pp. : 637-647

Elsevier

Access to resources Recommend Favorite

An Altered Histaminergic Innervation of the Substantia Nigra in Parkinson's Disease

By Anichtchik O.V.   Rinne J.O.   Kalimo H.   Panula P.  

Experimental Neurology, Vol. 163, Iss. 1, 2000-05 ,pp. : 20-30

Elsevier

Access to resources Recommend Favorite

Morphometry of the human substantia nigra in ageing and Parkinson’s disease

By Rudow Gay   O’Brien Richard   Savonenko Alena   Resnick Susan   Zonderman Alan   Pletnikova Olga   Marsh Laura   Dawson Ted   Crain Barbara   West Mark   Troncoso Juan  

Acta Neuropathologica, Vol. 115, Iss. 4, 2008-04 ,pp. : 461-470

Springer Publishing Company

Access to resources Recommend Favorite

α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease

By Halliday Glenda M.   Ophof Anita   Broe Melissa   Jensen Poul H.   Kettle Emma   Fedorow Heidi   Cartwright Michael I.   Griffiths Francine M.   Shepherd Claire E.   Double Kay L.  

Brain, Vol. 128, Iss. 11, 2005-11 ,pp. : 2654-2664

Oxford University Press

Access to resources Recommend Favorite